Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Sambuddha Chakraborty & Ashwini Chauhan. (2023) Fighting the flu: a brief review on anti-influenza agents. Biotechnology and Genetic Engineering Reviews 0:0, pages 1-52.
Read now
Read now
Articles from other publishers (32)
Yogesh Yadav, Rajdeep Tyagi, Ramesh Kumar & Ram Sagar. (2023) Conformationally locked sugar derivatives and analogues as potential neuraminidase inhibitors. European Journal of Medicinal Chemistry 255, pages 115410.
Crossref
Crossref
Ruifang Jia, Jiwei Zhang, Fangyuan Shi, Anna Bonomini, Camilla Lucca, Chiara Bertagnin, Jian Zhang, Chuanfeng Liu, Huinan Jia, Yuanmin Jiang, Xiuli Ma, Arianna Loregian, Bing Huang, Peng Zhan & Xinyong Liu. (2023) Discovery of N-substituted oseltamivir derivatives as novel neuraminidase inhibitors with improved drug resistance profiles and favorable drug-like properties. European Journal of Medicinal Chemistry 252, pages 115275.
Crossref
Crossref
Rashmi Kumari, Suresh D. Sharma, Amrita Kumar, Zachary Ende, Margarita Mishina, Yuanyuan Wang, Zackary Falls, Ram Samudrala, Jan Pohl, Paul R. Knight & Suryaprakash Sambhara. (2023) Antiviral Approaches against Influenza Virus. Clinical Microbiology Reviews 36:1.
Crossref
Crossref
Yuheng Huang, Zhen Wang, Senbiao Fang, Ying Tan, Jiajun Chen, Jiaming Xie, Zhengchao Tu, Weihuan Huang, Ning Li & Haiyan Tian. (2023) Rapid detection of traditional Chinese medicine with neuraminidase inhibitory activities based on high-throughput and virtual screening strategy. Phytomedicine Plus 3:1, pages 100417.
Crossref
Crossref
Kuanglei Wang, Huicong Zhang & Yongshou Tian. (2022) The current strategies of optimization of oseltamivir against mutant neuraminidases of influenza A：A review. European Journal of Medicinal Chemistry 243, pages 114711.
Crossref
Crossref
Mario Karolyi, Lukas Kaltenegger, Erich Pawelka, Avelino Kuran, Moritz Platzer, David Totschnig, Franz Koenig, Wolfgang Hoepler, Hermann Laferl, Sara Omid, Tamara Seitz, Marianna Traugott, Sigrun Arthofer, Lea Erlbeck, Stefan Jaeger, Alina Kettenbach, Alice Assinger, Christoph Wenisch & Alexander Zoufaly. (2022) Early administration of remdesivir may reduce mortality in hospitalized COVID-19 patients. Wiener klinische Wochenschrift 134:23-24, pages 883-891.
Crossref
Crossref
Julia M. Smyk, Natalia Szydłowska, Weronika Szulc & Anna Majewska. (2022) Evolution of Influenza Viruses—Drug Resistance, Treatment Options, and Prospects. International Journal of Molecular Sciences 23:20, pages 12244.
Crossref
Crossref
Vladimir V. Zarubaev, Angelica V. Garshinina, Alexandrina S. Volobueva, Alexander V. Slita, Olga I. Yarovaya, Vladimir V. Bykov, Klim A. Leonov, Valery S. Motov, Veniamin A. Khazanov & Nariman F. Salakhutdinov. (2022) Optimization of application schedule of camphecene, a novel anti‐influenza compound, based on its pharmacokinetic characteristics. Fundamental & Clinical Pharmacology 36:3, pages 518-525.
Crossref
Crossref
Magdalena Świerczyńska, Dagmara M. Mirowska-Guzel & Edyta Pindelska. (2022) Antiviral Drugs in Influenza. International Journal of Environmental Research and Public Health 19:5, pages 3018.
Crossref
Crossref
Sabina Lipničanová, Barbora Legerská, Daniela Chmelová, Miroslav Ondrejovič & Stanislav Miertuš. (2022) Optimization of an Inclusion Body-Based Production of the Influenza Virus Neuraminidase in Escherichia coli. Biomolecules 12:2, pages 331.
Crossref
Crossref
Tianhang Chen, Haixia Du, Huifen Zhou, Jiehong Yang, Jiaqi Zhu, Xin Tong, Yuting Yang, Jiayang Wan, Yichen Fan, Yiyu Lu, Yu He & Haitong Wan. (2022) Screening of Antiviral Components of Yinhuapinggan Granule and Protective Effects of Yinhuapinggan Granule on MDCK Cells with Influenza A/H1N1 Virus. BioMed Research International 2022, pages 1-14.
Crossref
Crossref
Yung-Kuo Lee, Wen-Chiu Chang, Ekambaranellore Prakash, Yu-Ju Peng, Zhi-Jay Tu, Chun-Hung Lin, Pang-Hung Hsu & Chuan-Fa Chang. (2022) Carbohydrate Ligands for COVID-19 Spike Proteins. Viruses 14:2, pages 330.
Crossref
Crossref
Dessislava Jereva, Maria Angelova, Ivanka Tsakovska, Petko Alov, Ilza Pajeva, Maria Miteva & Tania Pencheva. 2022. Contemporary Methods in Bioinformatics and Biomedicine and Their Applications. Contemporary Methods in Bioinformatics and Biomedicine and Their Applications
67
78
.
Zhi Jian Zhong, Xiao Tong Hu, Li Ping Cheng, Xing Yong Zhang, Qiang Zhang & Ju Zhang. (2021) Discovery of novel thiophene derivatives as potent neuraminidase inhibitors. European Journal of Medicinal Chemistry 225, pages 113762.
Crossref
Crossref
Jizhen Shang, Yuchun Qiao, Guojiang Mao, Lisheng Qian, Guodong Liu & Hua Wang. (2021) Bleomycin-Fe(II) agent with potentiality for treating drug-resistant H1N1 influenza virus: A study using electrochemical RNA beacons. Analytica Chimica Acta 1180, pages 338862.
Crossref
Crossref
Amanda L. Skarlupka, Anne-Gaelle Bebin-Blackwell, Spencer F. Sumner & Ted M. Ross. (2021) Universal Influenza Virus Neuraminidase Vaccine Elicits Protective Immune Responses against Human Seasonal and Pre-pandemic Strains. Journal of Virology 95:17.
Crossref
Crossref
Masato Takeuchi & Koji Kawakami. (2021) Association of baloxavir marboxil prescription with subsequent medical resource utilization among school‐aged children with influenza. Pharmacoepidemiology and Drug Safety 30:6, pages 779-786.
Crossref
Crossref
Robert Susło, Piotr Pobrotyn, Lidia Brydak, Łukasz Rypicz, Urszula Grata-Borkowska & Jarosław Drobnik. (2021) Seasonal Influenza and Low Flu Vaccination Coverage as Important Factors Modifying the Costs and Availability of Hospital Services in Poland: A Retrospective Comparative Study. International Journal of Environmental Research and Public Health 18:10, pages 5173.
Crossref
Crossref
Uwe K. Simon. (2021) An Instant Update on Viruses. The American Biology Teacher 83:3, pages 147-153.
Crossref
Crossref
Noble Selasi Gati, Ozan Altan Altinok, Sriram Kumar, Verónica A Ferrando, Joachim Kurtz, Michael Quante, Stephan Ludwig & Alexander Mellmann. (2021)
Integrating evolutionary aspects into dual-use discussion: the cases of influenza virus and enterohemorrhagic
Escherichia coli
. Evolution, Medicine, and Public Health 9:1, pages 383-392.
Crossref
Crossref
Olivier Bocquet, Amandine Wahart, Thomas Sarazin, Elise Vincent, Christophe Schneider, Anne Fougerat, Stéphanie Gayral, Aubéri Henry, Sébastien Blaise, Béatrice Romier-Crouzet, Camille Boulagnon, Stéphane Jaisson, Pr. Philippe Gillery, Amar Bennasroune, Hervé Sartelet, Muriel Laffargue, Pr. Laurent Martiny, Pr. Laurent Duca & Pascal Maurice. (2021) Adverse effects of oseltamivir phosphate therapy on the liver of LDLR-/- mice without any benefit on atherosclerosis and thrombosis. Journal of Cardiovascular Pharmacology Publish Ahead of Print.
Crossref
Crossref
Hang Yin, Ning Jiang, Wenhao Shi, Xiaojuan Chi, Sairu Liu, Ji-Long Chen & Song Wang. (2021) Development and Effects of Influenza Antiviral Drugs. Molecules 26:4, pages 810.
Crossref
Crossref
Bálint Mészáros, Hugo Sámano-Sánchez, Jesús Alvarado-Valverde, Jelena ČalyševaElizabeth Martínez-Pérez, Renato Alves, Denis C. Shields, Manjeet Kumar, Friedrich Rippmann, Lucía B. Chemes & Toby J. Gibson. (2021) Short linear motif candidates in the cell entry system used by SARS-CoV-2 and their potential therapeutic implications. Science Signaling 14:665.
Crossref
Crossref
Matheus V.C. Grahl, Allan M. Alcará, Ana Paula A. Perin, Carlo F. Moro, Éderson S.M. Pinto, Bruno C. Feltes, Isadora M. Ghilardi, Felipe V.F. Rodrigues, Marcio Dorn, Jaderson C. da Costa, Osmar Norberto de Souza & Rodrigo Ligabue-Braun. (2021) Evaluation of drug repositioning by molecular docking of pharmaceutical resources available in the Brazilian healthcare system against SARS-CoV-2. Informatics in Medicine Unlocked 23, pages 100539.
Crossref
Crossref
Klaudia Wieczorek, Barbara Szutkowska & Elzbieta Kierzek. (2020) Anti-Influenza Strategies Based on Nanoparticle Applications. Pathogens 9:12, pages 1020.
Crossref
Crossref
Chieh-Wen Lo, Chia-Chen Pi, You-Ting Chen & Hui-Wen Chen. (2020) Vigna radiata (L.) R. Wilczek Extract Inhibits Influenza A Virus by Targeting Viral Attachment, Penetration, Assembly, and Release. Frontiers in Pharmacology 11.
Crossref
Crossref
Sumit Kumar, Steven Goicoechea, Sonu Kumar, Catherine M. Pearce, Ravi Durvasula, Prakasha Kempaiah, Brijesh Rathi & Poonam. (2020) Oseltamivir analogs with potent anti-influenza virus activity. Drug Discovery Today 25:8, pages 1389-1402.
Crossref
Crossref
Paul E. Verweij, Bart J. A. Rijnders, Roger J. M. Brüggemann, Elie Azoulay, Matteo Bassetti, Stijn Blot, Thierry Calandra, Cornelius J. Clancy, Oliver A. Cornely, Tom Chiller, Pieter Depuydt, Daniele Roberto Giacobbe, Nico A. F. Janssen, Bart-Jan Kullberg, Katrien Lagrou, Cornelia Lass-Flörl, Russell E. Lewis, Peter Wei-Lun Liu, Olivier Lortholary, Johan Maertens, Ignacio Martin-Loeches, M. Hong Nguyen, Thomas F. Patterson, Thomas R. Rogers, Jeroen A. Schouten, Isabel Spriet, Lore Vanderbeke, Joost Wauters & Frank L. van de Veerdonk. (2020) Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion. Intensive Care Medicine 46:8, pages 1524-1535.
Crossref
Crossref
Koichi Fukase. (2020) Glycan related drugs糖鎖関連医薬. Drug Delivery System 35:3, pages 240-253.
Crossref
Crossref
Mart Toots & Richard K. Plemper. (2020) Next-generation direct-acting influenza therapeutics. Translational Research 220, pages 33-42.
Crossref
Crossref
Shane O'Sullivan, Antoni Torres, Alejandro Rodriguez & Ignacio Martin-Loeches. (2020) Influenza management with new therapies. Current Opinion in Pulmonary Medicine 26:3, pages 215-221.
Crossref
Crossref
Sonia Mohammad, Klaus Korn, Barbara Schellhaas, Markus F Neurath & Ruediger S Goertz. (2019) Clinical Characteristics of Influenza in Season 2017/2018 in a German Emergency Department: A Retrospective Analysis. Microbiology Insights 12, pages 117863611989030.
Crossref
Crossref